This file photo illustration picture shows vials with Covid-19 Vaccine stickers attached, with the logo of US pharmaceutical company Pfizer, on November 17,2020. - AFP
WASHINGTON: The U.S. Food and Drug Administration's outside advisers will meet on Dec. 10 to discuss whether to authorize the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech for emergency use, the agency said on Friday.
The move comes after Pfizer applied for the authorization of its COVID-19 vaccine earlier in the day, the first such application in a major step toward providing protection against the new coronavirus.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
